Aclaris Therapeutics's chart data is dated 2026-10-08. Recorded technical signals: RSI rebound. There are 7 published signal records.
Aclaris Therapeutics last closed at $3.79 (+11.47%) on 2026-10-08. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -7.1×. Its overall grade ranks 566 of 738 stocks in Healthcare.
About this company
Aclaris Therapeutics last closed at $3.79 (+11.47%) on 2026-10-08. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 566/738
Valuation grade B-
Related stocks
- AbbVieCompetitor
면역·염증성 질환 치료제 시장에서 경쟁
- PfizerCompetitor
염증/면역 질환 파이프라인 개발 경쟁
- Bristol-Myers SquibbCompetitor
면역학·염증 치료제 분야의 대형 경쟁사
About Aclaris Therapeutics
- What technical signals does Aclaris Therapeutics (ACRS) have?
- Aclaris Therapeutics current technical signals: RSI rebound.
- Is Aclaris Therapeutics a cup-and-handle pattern?
- No. Aclaris Therapeutics has no valid Cup signal right now.
- What published figures are available for Aclaris Therapeutics?
- Market cap: $410.63M. Trailing 12 months PER: -7.1×. Latest quarter PBR: 4.34×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Aclaris Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.